1. Home
  2. HERE vs TLSA Comparison

HERE vs TLSA Comparison

Compare HERE & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HERE

Here Group Limited American Depositary Shares

N/A

Current Price

$2.25

Market Cap

193.1M

Sector

Real Estate

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$1.12

Market Cap

155.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HERE
TLSA
Founded
2019
2013
Country
China
United Kingdom
Employees
714
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.1M
155.3M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
HERE
TLSA
Price
$2.25
$1.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
164.2K
284.0K
Earning Date
06-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$79.29
N/A
P/E Ratio
$2.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$1.04
52 Week High
$5.80
$2.60

Technical Indicators

Market Signals
Indicator
HERE
TLSA
Relative Strength Index (RSI) 45.40 32.89
Support Level $2.03 N/A
Resistance Level $2.50 $1.61
Average True Range (ATR) 0.22 0.11
MACD 0.05 -0.03
Stochastic Oscillator 73.50 9.43

Price Performance

Historical Comparison
HERE
TLSA

About HERE Here Group Limited American Depositary Shares

Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: